Symptoms

WHO report: 17 million in EU may have suffered long COVID-19 JERUSALEM (AP) — New research suggests at least 17 million people in the European Union may have experienced long COVID-19 symptoms during the first two years of the coronavirus pandemic, with women more likely than men to suffer from the condition, the World Health Organization said Tuesday. AP NEWS

...

Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men Cases of myocarditis – an inflammation of the heart muscle – following a third dose of the Pfizer vaccine are rare and typically mild, research from Israel shows. www.heart.org

...

10 key questions about monkeypox the world needs to answer Monkeypox is not a new disease. But scant attention paid to it for decades means there are big unanswered questions about the disease and the virus that causes it. Megan Molteni STAT

...

Study: Pfizer COVID pill showed no benefit in younger adults WASHINGTON (AP) — Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday. AP NEWS

...

The researchers found that Paxlovid reduced hospitalizations among people 65 and older by roughly 75% when given shortly after infection. That’s consistent with earlier results used to authorize the drug in the U.S. and other nations.